Dashboard
Manage Tickers

CRVOCervoMed Inc.

Nasdaq www.cervomed.com


$ 19.31 $ -0.75 (-3.8 %)    

Friday, 14-Jun-2024 15:59:43 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 19.01
$ 19.28
$ 0.00 x 0
$ 0.00 x 0
$ 18.75 - $ 20.02
$ 4.28 - $ 26.38
30,258
na
156.9M
$ 0.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-18-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-17-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-17-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-19-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-25-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 04-03-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cervomed-completes-enrollment-in-phase-2b-rewind-lb-clinical-trial-of-neflamapimod-for-the-treatment-of-patients-with-dementia-with-lewy-bodies
CervoMed Completes Enrollment In Phase 2b ...
06/11/2024 12:27:14

- Topline data expected in December 2024 - - Phase 2b design optimized for success; clear path to market in this high value ind...

jones-trading-initiates-coverage-on-cervomed-with-buy-rating-announces-price-target-of-70
Jones Trading Initiates Coverage On CervoM...
05/29/2024 10:38:38

Jones Trading analyst Soumit Roy initiates coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and announces Price Target o...

why-virios-therapeutics-shares-are-trading-lower-by-around-48-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Virios Therapeutics Shares Are Trading...
05/20/2024 17:28:52

cervomed-names-william-elder-as-chief-financial-officer-effective-june-1-2024
CervoMed Names William Elder As Chief Fina...
05/20/2024 12:04:47

CervoMed Inc. (NASDAQ:CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, to...

cervomed-q1-eps-041-misses-039-estimate-sales-235m-beat-135m-estimate
CervoMed Q1 EPS $(0.41) Misses $(0.39) Est...
05/15/2024 12:14:46

CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.39) by...

disney-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday
Disney To Rally Around 10%? Here Are 10 To...
04/08/2024 12:00:36

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

canaccord-genuity-maintains-buy-on-cervomed-raises-price-target-to-65
Canaccord Genuity Maintains Buy on CervoMe...
04/08/2024 11:37:59

Canaccord Genuity analyst Sumant Kulkarni maintains CervoMed (NASDAQ:CRVO) with a Buy and raises the price target from $50 t...

cervomed-announces-private-placement-financing-including-50m-financing-upfront-with-up-to-an-additional-994m-tied-to-exercise-of-warrants
CervoMed Announces Private Placement Finan...
03/28/2024 12:35:08

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

cervomed-announces-presentation-of-biomarker-data-from-the-ascend-lb-phase-2a-trial-and-preclinical-data-supporting-potential-of-neflamapimod-in-tau-mediated-disease-at-adpd--2024
CervoMed Announces Presentation Of Biomark...
03/05/2024 13:01:13

- Neflamapimod led to significant reduction compared to placebo in plasma levels of glial fibrillary acidic protein (GFAP) - Ne...

canaccord-genuity-initiates-coverage-on-cervomed-with-buy-rating-announces-price-target-of-50
Canaccord Genuity Initiates Coverage On Ce...
02/15/2024 12:18:23

Canaccord Genuity analyst Sumant Kulkarni initiates coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and announces Price...

cervomed-publishes-results-from-ascend-lb-phase-2a-trial-evaluating-treatment-of-neflamapimod-in-dementia-with-lewy-bodies
CervoMed Publishes Results From AscenD-LB ...
02/12/2024 13:08:03

-Integrated summary of all previously published Phase 2a clinical results, together with the first peer reviewed publication of...

cervomed-appoints-joshua-boger-as-board-chair
CervoMed Appoints Joshua Boger As Board Chair
02/07/2024 13:35:27

Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals CervoMed on track to complete enrollment i...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/06/2023 13:06:45

cervomed-announced-oral-presentation-at-ctad-2023-highlighting-learnings-from-phase-2a-which-optimized--design-of-phase-2b-clinical-study-of-neflamapimod-in-dementia-with-lewy-bodies
CervoMed Announced Oral Presentation At CT...
10/25/2023 18:51:37

CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain,...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
10/20/2023 21:31:30

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
09/07/2023 17:31:10

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
09/07/2023 13:06:05

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
08/31/2023 21:31:53

ai-eipp-holdings-llc-reports-999-passive-stake-in-cervomed-inc-as-of-aug-16
AI EIPP Holdings Llc Reports 9.99% Passive...
08/28/2023 20:08:03

-SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)